AI Assistant
Blog
Pricing
Log In
Sign Up
<b>Phase Ⅰ Clinical Trial of NE-58095 DR, a Risedronate Delayed-Release Tablet: </b><b>Dose Escalation and Food Effect </b>
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
